医学
人工智能
危害
人口统计学的
个性化医疗
精密医学
重症监护医学
梅德林
机器学习
医学物理学
病理
计算机科学
生物信息学
人口学
社会学
生物
法学
政治学
作者
Thomas F. Lüscher,Florian A. Wenzl,Fabrizio D’Ascenzo,Paul A. Friedman,Charalambos Antoniades
标识
DOI:10.1093/eurheartj/ehae465
摘要
Clinical medicine requires the integration of various forms of patient data including demographics, symptom characteristics, electrocardiogram findings, laboratory values, biomarker levels, and imaging studies. Decision-making on the optimal management should be based on a high probability that the envisaged treatment is appropriate, provides benefit, and bears no or little potential harm. To that end, personalized risk-benefit considerations should guide the management of individual patients to achieve optimal results. These basic clinical tasks have become more and more challenging with the massively growing data now available; artificial intelligence and machine learning (AI/ML) can provide assistance for clinicians by obtaining and comprehensively preparing the history of patients, analysing face and voice and other clinical features, by integrating laboratory results, biomarkers, and imaging. Furthermore, AI/ML can provide a comprehensive risk assessment as a basis of optimal acute and chronic care. The clinical usefulness of AI/ML algorithms should be carefully assessed, validated with confirmation datasets before clinical use, and repeatedly re-evaluated as patient phenotypes change. This review provides an overview of the current data revolution that has changed and will continue to change the face of clinical medicine radically, if properly used, to the benefit of physicians and patients alike.
科研通智能强力驱动
Strongly Powered by AbleSci AI